7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Gut Health

Blood Thinners Before a Barrett’s Biopsy or Ablation: Why Timing Is Planned With Your Team

24 min read
Blood Thinners Before a Barrett’s Biopsy or Ablation: Why Timing Is Planned With Your Team

Key Takeaways

  • Diagnostic upper endoscopy with biopsies is classed as a low bleeding-risk procedure by endoscopy societies, so anticoagulants and antiplatelets are often continued rather than stopped.
  • Ablation and mucosal resection for Barrett's create a wound many times larger than a biopsy pinch and can bleed days later during healing, which is why these procedures more often involve a planned medication pause.
  • Warfarin acts by slowing production of clotting proteins and wears off over days, whereas direct oral anticoagulants block one factor and fade within about a day or two in people with normal kidney function, so interruption plans differ by class.
  • Low-dose aspirin taken for heart or stroke protection is the medicine most often stopped without advice and the one guidance most consistently says should usually continue.
  • The reason you take a blood thinner, such as a mechanical valve, recent clot or recent coronary stent, drives the clot risk side of the decision more than the drug's name does.
  • The restart date after a procedure is as important as the stop date, and both should be written down before you leave the unit.
Quick Answer

Many people do not need to stop blood thinners before an endoscopy biopsy of Barrett's esophagus, because small biopsies carry a low bleeding risk and stopping an anticoagulant or antiplatelet raises clot risk. Ablation and other tissue-removing treatments bleed more, so some medicines may be paused. The plan depends on the drug, why you take it, and the procedure, and it is always set by your prescribing clinician and endoscopy team together.

The appointment letter arrives with a list of instructions, and one line stops you cold: bring details of any blood-thinning medicines. You take one every morning because of a stroke scare two years ago, and now you are booked for a repeat look at your Barrett’s esophagus, possibly with biopsies, possibly with heat treatment. Do you keep taking the tablet? Skip it? Call someone? The letter does not say, and the internet says everything at once.

That uncertainty is common, and the honest answer is that whether to stop blood thinners before endoscopy biopsy is not a yes-or-no question anyone can answer from a search box. It is a weighing exercise: the chance of bleeding from the procedure on one side, the chance of a clot forming if the medicine is paused on the other.

This article walks through how that weighing is done, why a biopsy and an ablation land in different places on the scale, and what to ask so the decision is made deliberately, with your team, rather than by accident the night before.

Do you need to stop blood thinners before an endoscopy biopsy?

Start with the reassuring part. A biopsy taken during an upper endoscopy is a pinch of tissue, usually a few millimeters across, lifted from the lining of the esophagus with tiny forceps passed down the scope. The wound it leaves is shallow, the esophageal lining heals quickly, and the endoscopist can see the spot and treat any oozing on the screen. For that reason, endoscopy societies place diagnostic endoscopy with biopsy in the low bleeding-risk category, and many people are told to keep taking their usual anticoagulant or antiplatelet medicine right through the appointment.

An anticoagulant is a medicine that slows the chemical cascade that turns liquid blood into a clot; warfarin and the newer direct oral anticoagulants belong here. An antiplatelet, such as aspirin or clopidogrel, works differently, making the small cell fragments called platelets less sticky. Both are grouped under the everyday label of blood thinners, though neither actually thins the blood; they simply make clotting slower or less likely.

Why not pause everything to be safe? Because pausing is not free. The condition that earned you the prescription, whether atrial fibrillation, a past clot in the leg or lung, a mechanical heart valve or a coronary stent, does not pause with it. Guidance from the National Health Service is blunt on this point: people should not stop an anticoagulant without speaking to the clinician who prescribed it, because doing so raises the risk of a serious clot.

So the framework is simple even when the details are not. Low-risk procedure plus low clot risk usually means continue. High-risk procedure, such as ablation or resection of Barrett’s tissue, plus a medicine that cannot be reversed quickly may mean a planned, short interruption. Everything in between is a conversation, and the rest of this article is about having that conversation well.

What actually happens during a Barrett's biopsy or ablation

Barrett’s esophagus is a change in the lining of the lower esophagus, where years of acid reflux have replaced the normal pale, skin-like cells with salmon-pink cells that resemble the intestine. On its own it causes no symptoms beyond the reflux that led to it, but it is watched because a small proportion of people go on to develop precancerous change called dysplasia, and a smaller proportion still develop esophageal cancer. Mayo Clinic describes that overall cancer risk as small, which is why the strategy is periodic checking rather than urgent treatment for most people.

Doctor examining patient with stethoscope in clinic: What actually happens during a Barrett's biopsy or ablation

A surveillance endoscopy is a camera examination. You lie on your left side, sedation or a throat spray is given, and a flexible tube about the width of a finger passes through the mouth into the esophagus and stomach. The endoscopist inspects the Barrett’s segment, often with dye or special light filters, and takes biopsies at set intervals along its length. These samples go to a pathologist who looks for dysplasia under a microscope. The whole examination commonly takes around 15 minutes, according to the NHS gastroscopy guidance, and most people go home the same day.

Ablation is a different animal. Radiofrequency ablation uses a small balloon or paddle to deliver controlled heat that destroys the abnormal surface layer so healthy lining can grow back. Endoscopic mucosal resection lifts and cuts away a raised area or nodule. Both intentionally create a wound far larger than a biopsy pinch, sometimes covering the full circumference of the lower esophagus for several centimeters.

That difference in wound size is the single most important fact in this whole topic. A biopsy is a scratch; an ablation is a deliberate burn. The bleeding calculus follows from there.

Why a biopsy and an ablation sit in different bleeding-risk categories

Endoscopy guidelines sort procedures into two rough bins. Low-risk procedures include diagnostic endoscopy with or without biopsy, where bleeding is uncommon, usually minor, and visible to the operator who can treat it on the spot with a clip or a burst of coagulation. High-risk procedures include anything that removes or destroys a substantial area of tissue: polyp removal in the colon, dilation of a narrowed esophagus, and the ablation and resection techniques used for dysplastic Barrett’s.

Three mechanisms explain the gap. First, surface area. A biopsy exposes a few square millimeters of small vessels; a circumferential ablation exposes a band of raw tissue with many more vessel openings. Second, depth. Biopsy forceps take the very top layer; resection reaches deeper, closer to larger submucosal vessels. Third, timing. Biopsy bleeding, when it happens, occurs during the procedure where it can be seen. Ablation and resection can bleed later, in the days after, as the burned surface sloughs off and exposes fresh tissue, at which point nobody is watching.

That delayed-bleeding window is precisely where anticoagulants matter most. Restarting a blood thinner too early after a high-risk procedure can convert a trickle into a significant bleed; restarting too late leaves the underlying clot risk uncovered. This is why the restart date is often discussed as carefully as the stop date.

For the person reading a letter about a surveillance endoscopy, the practical translation is this: if the plan is biopsies only, the default leans toward continuing your medicine. If the letter mentions ablation, resection or treatment of dysplasia, expect a specific medication plan, and expect it to involve the clinician who prescribed the blood thinner, not just the endoscopy unit.

Blood thinners are not one drug: anticoagulants and antiplatelets explained

Grouping every blood-thinning medicine under one word hides the reason preparation differs so much from person to person. The medicines work on different parts of the clotting system and wear off at very different speeds.

Doctor consulting with senior male patient about medication: Blood thinners are not one drug: anticoagulants and antiplatele

Warfarin blocks the liver’s use of vitamin K to make several clotting proteins. Because it acts on production rather than on existing proteins, its effect builds over days and fades over days when stopped. Its intensity is measured by the INR, a blood test that reports how much longer than normal blood takes to clot; the American Heart Association’s patient guide to warfarin explains that the target range varies with the reason for treatment. The slow on-and-off profile is exactly why any interruption for a procedure has to be planned in advance and often checked with a test.

The direct oral anticoagulants, often shortened to DOACs, block a single clotting factor directly. They start working within hours and their effect declines within a day or two of the last dose in people with normal kidney function, which is why interruptions for these medicines are typically shorter. Kidney function matters because the drugs are partly cleared by the kidneys; someone with reduced function holds on to the effect longer, and the team will factor that in.

Antiplatelets act on platelets rather than clotting proteins. Aspirin permanently disables an enzyme in each platelet it meets, so its effect lasts for the life of that platelet and only fades as the body makes new ones over several days. Clopidogrel and its relatives behave similarly. Injectable anticoagulants, such as low-molecular-weight heparin, are sometimes used in hospital and act quickly, which is why they occasionally appear in bridging plans.

None of this is information for self-management. It is context for understanding why one person is told to carry on and another is given a detailed calendar.

Aspirin before endoscopy: why low-dose aspirin is often continued

The most searched version of this whole question is about aspirin, and the answer surprises people: for a diagnostic endoscopy with biopsies, low-dose aspirin taken for heart or stroke protection is usually continued. Guidelines treat it as compatible with low-risk procedures, and many units also allow it through higher-risk procedures unless the endoscopist specifically asks otherwise.

The logic rests on two facts. The bleeding contribution of aspirin alone during biopsy is small and manageable under direct vision. The consequence of stopping it, for someone who takes it after a heart attack or with a coronary stent, can be a clot forming inside a coronary artery. The NHS low-dose aspirin guidance advises against stopping it without medical advice for exactly this reason, and cardiology guidance from the American Heart Association emphasizes that people with stents are at particular risk if antiplatelet therapy is interrupted early.

There is an important distinction between aspirin taken alone and aspirin taken with a second antiplatelet such as clopidogrel, a combination often prescribed for a year or so after a stent or heart attack. Dual therapy raises bleeding risk more than either drug alone, and the second agent is the one more likely to be paused before a high-risk procedure, while aspirin continues as the safety net. The timing of that pause, and whether it is acceptable at all given the age of the stent, is a cardiology decision that the endoscopy team will request rather than make.

People also ask about aspirin taken for pain rather than prevention, or about over-the-counter anti-inflammatory painkillers such as ibuprofen and naproxen, which also affect platelets. These are handled case by case, and the pre-assessment call is the moment to mention them. The general lesson stands: aspirin is the medicine people most often stop on their own, and the one they most often should not.

What meds to stop before endoscopy: how the list is actually built

Pre-assessment nurses ask about every medicine for a reason, and the resulting plan is built from three inputs rather than a fixed list. The first is the procedure’s bleeding category. The second is the drug’s mechanism and how quickly it wears off. The third is your personal clot risk, which comes from the reason you were prescribed the medicine and from other conditions such as kidney function.

The table below summarizes how the main classes are usually approached. It describes typical patterns from endoscopy society guidance, not instructions; every cell can change based on individual circumstances, and the decision belongs to your prescribing clinician working with the endoscopy team.

Medicine class How it works Diagnostic endoscopy with biopsy Ablation or resection
Low-dose aspirin Permanently makes platelets less sticky Usually continued Often continued; team confirms
Other antiplatelets (e.g., clopidogrel) Blocks a platelet activation receptor Usually continued Often paused; cardiology input if a stent is involved
Warfarin Reduces production of vitamin K-dependent clotting proteins Usually continued if INR in range Usually paused in advance; INR checked; bridging considered only in high clot-risk cases
Direct oral anticoagulants Directly block one clotting factor Often continued or morning dose omitted Usually paused briefly; timing depends on kidney function
Injectable anticoagulants Rapid-acting, short duration Individual plan Individual plan

Notice what the table does not contain: days, doses or counts. Those figures exist in professional guidelines, but they are adjusted for individual kidney function, INR results, stent age and clot history, which is why a number copied from a website can be wrong for the person copying it.

Other medicines come up too. Diabetes medicines may need adjusting because of fasting, iron tablets can obscure the view of the lining, and some units ask about supplements such as fish oil or high-dose vitamin E. None of these should be stopped on your own initiative; list them, and let the team decide.

Who is usually asked to pause, and who is usually asked to keep going

Two people can take the same anticoagulant and receive opposite instructions for the same procedure, because the deciding factor is what happens to them if the drug is interrupted.

People commonly asked to keep taking their medicine include those having biopsies only, those on a single antiplatelet for prevention, and those whose anticoagulant treats a lower-risk condition such as atrial fibrillation without prior stroke. For them the arithmetic favors continuity: the biopsy will almost certainly be fine, and the small clot risk of a pause is not worth taking.

People more likely to be given a planned interruption are those having ablation or resection, particularly if they take warfarin or a direct oral anticoagulant. Here the procedure’s bleeding risk is high enough to justify a short gap, provided the underlying condition can tolerate one. Some, such as those with a mechanical heart valve or a clot within the past few months, sit in a high clot-risk group where a pause is either avoided, shortened as far as possible, or covered with an injectable bridging anticoagulant chosen by the prescribing team.

Then there is the group usually asked to wait for the procedure itself rather than for the medicine to be adjusted. Someone with a coronary stent placed very recently, who must remain on dual antiplatelet therapy, may have a non-urgent ablation deferred until the mandatory period has passed. Someone with a recent pulmonary embolism may have surveillance endoscopy postponed for the same reason. Barrett’s without dysplasia is watched at intervals of a few years, according to Mayo Clinic, so a delay of weeks or months to make the medication picture safer rarely changes the outcome and often makes sense.

What all these groups share is that the instruction is personal. A friend’s experience, however similar it seems, is not a template.

Why the reason you take the blood thinner matters as much as the drug

Ask an endoscopy nurse the most useful thing to bring to pre-assessment and many will say: know why you take your blood thinner. The indication drives the risk on the clot side of the scale far more than the drug’s name does.

Atrial fibrillation, the irregular heart rhythm that lets blood pool and clot in the heart’s upper chambers, is the commonest reason for long-term anticoagulation. The stroke risk it carries varies enormously with age, blood pressure, diabetes and previous stroke, which is why one person with the condition may safely skip a few doses while another may not. A mechanical heart valve is at the opposite end: the artificial surface is highly prone to clot, and interruptions are handled with great caution. A venous clot in the leg or lung is time-sensitive; the risk of recurrence is highest in the first months and falls afterward, so the same person may be treated differently depending on how long ago the clot occurred.

On the antiplatelet side, the question is usually about stents. A coronary stent is a small mesh tube holding an artery open; until the artery lining grows over it, the bare metal can trigger a clot, and clopidogrel or a relative plus aspirin prevents that. The American Heart Association warns that stopping these medicines early after stenting is a known cause of heart attack. Once the healing period is over, the second drug can often be paused briefly for a procedure, but that judgment belongs to cardiology.

This is why the endoscopy unit will often say they cannot answer the timing question themselves. They know the bleeding risk of the procedure. Only your prescribing clinician knows the clot risk you carry, and the plan needs both halves.

Endoscopy biopsy bleeding risk: what the mechanisms and evidence really say

People imagine biopsy bleeding as a hidden internal hemorrhage. The reality is more mundane and more reassuring. Esophageal biopsies bleed a little almost every time; that is how the endoscopist knows tissue has been taken. The trickle stops on its own within seconds to minutes because the vessels involved are tiny and the lining contracts around them. Significant bleeding requiring treatment is uncommon, and when it occurs it is usually seen and dealt with during the procedure itself, using a clip, a small injection or heat applied through the scope.

Does an anticoagulant change that picture? It lengthens the trickle and, in the rare case of a larger vessel, increases the chance that intervention is needed. It does not turn a routine biopsy into a dangerous one for most people, which is why guidance allows biopsies to proceed on continued therapy. Mayo Clinic lists bleeding among the risks of upper endoscopy while describing complications overall as rare, and MedlinePlus notes that the risk of bleeding is slightly higher when a biopsy is taken.

Ablation and resection are where the evidence shifts. Delayed bleeding after radiofrequency ablation or mucosal resection is a recognized complication precisely because the wound is large and heals over weeks. Add an anticoagulant restarted early, and the odds rise. This is the scenario guidelines are designed to prevent, and it is why the restart plan after a high-risk procedure is so specific.

The other half of the ledger deserves equal weight. Clots caused by stopping anticoagulation are less visible than bleeding, because they happen at home rather than on a screen, but strokes and pulmonary emboli are generally more dangerous than procedural bleeding that can be controlled under direct vision. A good plan holds both risks in view. A plan built only around avoiding bleeding is half a plan.

Barrett's ablation preparation: the week before, fasting, and the water question

Preparation for an ablation or a surveillance endoscopy follows a familiar shape. In the days before, expect a call or form asking about medicines, allergies, previous sedation and whether someone can take you home. If a medication change is planned, it will be written down with specific dates. If it is not written down, ask for it to be; verbal instructions about anticoagulants are where errors creep in.

Fasting matters because a stomach containing food or liquid can be inhaled during sedation and also blocks the view. NHS gastroscopy guidance describes not eating for around 6 to 8 hours beforehand, with clear fluids such as water usually permitted until a couple of hours before the appointment, though individual units set their own cutoffs and the letter’s instructions override any general figure. Sedation is not always used; a numbing throat spray alone is an option for some people, and the choice affects whether you can drive afterward.

Then the common panic: a mouthful of water taken by habit before the cutoff. Call the unit rather than assuming the appointment is lost. Small sips of water are often acceptable close to the procedure, and the staff will tell you whether the timing is a problem. What you should never do is skip a heart or blood pressure tablet you were told to take because you were worried about swallowing water; those are usually meant to be taken with a small sip.

For ablation specifically, some teams start or increase acid-suppressing medicine beforehand so the esophagus is as calm as possible for healing. Proton pump inhibitors, the class that shuts down acid pumps in the stomach lining, are the usual choice, and continuing them afterward is part of most treatment plans. Again, this is arranged by the team, not something to start on your own.

What the following days and weeks usually look like

After a surveillance endoscopy with biopsies, most people feel a mildly sore throat and some bloating from the air used to inflate the stomach, both settling within a day. Sedation leaves judgment slightly impaired for the rest of the day, which is why units ask that someone accompany you and that you avoid driving, alcohol and signing important documents until the next morning. Eating usually resumes once the throat spray has worn off and swallowing feels normal.

If your blood thinner was continued, nothing changes. If a dose was omitted, the discharge paperwork should state when to take the next one, and for biopsies alone that is often the same day or the following morning, as decided by the team. Biopsy results typically return within a couple of weeks and are discussed at a follow-up or by letter; Mayo Clinic notes that people with Barrett’s without dysplasia are usually rechecked every few years, while any dysplasia shortens that interval or prompts treatment.

After ablation, the picture is more involved. Chest discomfort and difficulty swallowing are expected for several days as the treated surface sloughs and regrows; a soft diet, acid suppression and plain pain relief agreed with the team are standard. This healing period is the delayed-bleeding window described earlier, and it is when the anticoagulant restart date matters most. Some people are asked to remain off their medicine for a few extra days; others restart promptly because their clot risk is high. Either way, the date should be explicit.

Ablation is rarely a single event. Several sessions over months are usual before the Barrett’s lining has been fully replaced, and each session repeats the same medication conversation, which becomes easier once the pattern is established.

What people often get wrong about stopping blood thinners before an endoscopy biopsy

The first and most dangerous mistake is stopping the medicine on your own because it seems the cautious thing to do. It feels cautious; it is the opposite. Bleeding from a biopsy is visible and treatable. A stroke from an unplanned pause is neither. If nobody has told you to stop, keep taking it and ask.

The second is treating aspirin as harmless to stop. Low-dose aspirin for heart protection is the medicine people most often skip before a procedure without asking, and the one with the clearest guidance that it should generally continue.

The third is assuming a biopsy is always taken. Endoscopists do not biopsy every stomach or esophagus they look at; they take samples when there is something to sample or a surveillance protocol requires it. For Barrett’s, biopsies are the whole point of the visit, but the number and depth are small, and the presence of biopsies alone does not make the procedure high risk.

The fourth is copying a stop schedule from a friend, a forum or a general website. Those numbers are averages for a population; yours is adjusted for kidney function, INR, stent age and clot history. A schedule that is right for one person can leave another unprotected or bleeding.

The fifth is believing that bridging with injections is the safe default whenever warfarin is paused. Bridging adds bleeding risk of its own, and current practice reserves it for people whose clot risk is high enough to justify that trade, a judgment made by the prescribing clinician.

The last is forgetting the restart. People remember the day they stopped and forget to ask when to begin again, then either restart too early during the healing window or, more often, drift for weeks without cover. Write both dates down before you leave.

Questions to ask your care team

The most productive pre-assessment conversations are short and specific. Bring a list of everything you take, including over-the-counter painkillers and supplements, and bring the answer to the one question that unlocks the rest: why was this blood thinner prescribed, and when did that event happen?

Then work through the following, ideally getting the answers in writing:

  • Is this appointment for biopsies only, or is ablation or resection planned? If it could become either, what is the medication plan for each scenario?
  • Do you need me to change anything about my anticoagulant or antiplatelet, and if so, who is making that decision, the endoscopy team or my prescribing clinician, and have they spoken to each other?
  • If a pause is planned, what is the exact last day to take it and the exact day to restart, and does that restart date change depending on what is done during the procedure?
  • Will my INR or kidney function be checked beforehand, and what happens to the plan if the result is out of range?
  • Do I keep taking my low-dose aspirin?
  • Is bridging with an injectable anticoagulant being considered, and if so, why for me?
  • What signs of bleeding or clotting should prompt a call, and which number do I ring out of hours?
  • If I have a coronary stent or a recent clot, has cardiology or the anticoagulation clinic confirmed the plan?

One more question is worth asking even though it feels awkward: if I forget and take a dose I was told to skip, what should I do? Units answer this every day, and knowing the answer in advance removes the temptation to hide a mistake or to skip the appointment silently. The goal of the conversation is not to negotiate the plan but to understand it well enough to follow it exactly.

When to call your doctor

Most people go home from a Barrett’s biopsy or ablation and have an uneventful recovery. A small number develop problems that need prompt attention, and because blood thinners are involved, both bleeding and clotting deserve attention in the days afterward.

Seek urgent medical help, calling emergency services if severe, for vomiting blood or material that looks like coffee grounds; black, tarry or maroon stools; feeling faint, sweaty or short of breath, especially on standing; a racing pulse with weakness; or chest pain that is new, crushing or spreading to the arm or jaw. Severe or worsening pain in the chest or upper abdomen, particularly with fever or pain on swallowing that is getting worse rather than better, can signal a tear or infection after ablation and needs same-day assessment.

On the clot side, watch for sudden weakness or numbness of the face, arm or leg, slurred speech, sudden confusion or loss of vision; a swollen, painful or warm calf; or sudden breathlessness with sharp chest pain on breathing in. These can indicate stroke, deep vein thrombosis or pulmonary embolism, and the risk is higher during and shortly after any interruption in anticoagulation.

Call the endoscopy unit or your prescribing clinician, rather than waiting for a routine follow-up, if you are unsure when to restart a medicine, if you took a dose you were told to omit, if you missed the restart date, or if mild bleeding such as a streak in saliva continues beyond the first day. The NHS advises that anyone on anticoagulants who has a fall or head injury should be assessed even if they feel well.

Every threshold above is a reason to make contact, not a diagnosis. The team that planned your procedure would far rather hear from you about something minor than not hear about something serious.

Frequently asked questions

Do they always take a biopsy during an endoscopy?

No. Biopsies are taken when the endoscopist sees something worth sampling or when a surveillance protocol requires it. For Barrett’s esophagus, biopsies are the main purpose of the visit, taken at set points along the abnormal segment so a pathologist can look for dysplasia. Even so, esophageal biopsies are small, shallow pinches, and their presence alone does not move a diagnostic endoscopy into the high bleeding-risk category.

I accidentally drank water before my endoscopy. What should I do?

Call the endoscopy unit and tell them what you drank and when. Small sips of clear water are often acceptable until a couple of hours before the procedure, and the staff will confirm whether your timing is a problem or whether the appointment needs adjusting. Do not skip the appointment or hide it; an honest call is safer than a guess, and staff handle this question every day.

What meds should you stop before an endoscopy?

There is no universal list, and the safest answer is none unless your team tells you otherwise. The plan is built from the procedure’s bleeding risk, each medicine’s mechanism, and your personal clot risk. Anticoagulants, antiplatelets, diabetes medicines and iron are the ones most commonly discussed. Bring a complete list, including over-the-counter painkillers and supplements, and let the pre-assessment team and your prescribing clinician decide what, if anything, changes.

How long before an endoscopy should I stop taking aspirin?

For most people having a diagnostic endoscopy with biopsies, aspirin taken for heart or stroke protection is not stopped at all. Guidelines treat low-dose aspirin as compatible with low-risk procedures because stopping it raises the risk of heart attack or stroke more than it lowers bleeding risk. If your endoscopist wants it paused for a higher-risk procedure, they will give specific written instructions after considering your cardiac history.

Is an endoscopy biopsy bleeding risk higher on blood thinners?

Slightly, but the practical effect is usually small. Biopsy sites almost always ooze briefly and stop on their own; an anticoagulant can lengthen that oozing and modestly increase the chance that a clip or heat is needed. Because the endoscopist sees the site directly, such bleeding is treated immediately. Significant bleeding needing further treatment remains uncommon, which is why biopsies are generally permitted on continued therapy.

Does Barrett's ablation preparation differ from a normal endoscopy?

Yes in two ways. Because ablation destroys a larger area of tissue, blood thinners are more likely to be paused in a planned way, with explicit stop and restart dates agreed with your prescribing clinician. Some teams also start or increase acid-suppressing medicine beforehand to help the esophagus heal. Fasting rules, sedation and the need for someone to take you home are the same as for a standard gastroscopy.

Can I take my other morning medicines with a sip of water on the day?

Usually yes, and heart and blood pressure medicines in particular are typically meant to be taken as normal with a small sip unless the letter says otherwise. Diabetes medicines are the main exception because fasting changes blood sugar, and the team will give specific instructions. If the letter is silent about a particular medicine, call the unit rather than guessing; never stop a tablet you were not told to stop.

What is bridging, and will I need it if warfarin is paused?

Bridging means covering a warfarin pause with a fast-acting injectable anticoagulant so clot protection continues while warfarin’s slow effect wears off and returns. It is not routine, because the injections add bleeding risk of their own. Current practice reserves bridging for people whose clot risk is particularly high, such as some with mechanical heart valves or a very recent clot. Your prescribing clinician makes that judgment, not the endoscopy unit.

What if I forgot and took a blood thinner dose I was told to skip?

Tell the endoscopy unit as soon as you realize, before you arrive if possible. Depending on the medicine and the planned procedure, the team may proceed with biopsies only, postpone any ablation, or reschedule. Taking the dose is not dangerous in itself; the risk comes from the team not knowing. Honesty lets them adapt the plan safely, and it happens far more often than people expect.

When will I restart my blood thinner after a Barrett's biopsy or ablation?

For biopsies alone on a continued medicine, nothing changes. If a dose was omitted, the discharge paperwork should state the restart, often the same day or next morning as decided by the team. After ablation or resection, restart is timed against the healing window when delayed bleeding can occur, balanced against your clot risk, so some people wait a few extra days. Ask for the exact date in writing.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 22, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.